3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Myeloid
2
Conditions
Melanoma
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Myeloid, Chronic-Phase
3
Polycythemia Vera
2
Neoplasm Metastasis
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Recurrence
1
Primary Myelofibrosis
1
Osteosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms
1
Metastatic Gastrointestinal Carcinoid Tumor
1
Lymphoma, Non-Hodgkin
1
Leukemia-Lymphoma, Adult T-Cell
1
Leukemia
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Graft vs Host Disease
1
Glioma
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Interventions
fludarabine phosphate
20
Peripheral Blood Stem Cell Transplantation
20
Cyclophosphamide
17
Busulfan
16
ruxolitinib
14
Tacrolimus
12
Whole-Body Irradiation
9
Mycophenolic Acid
9
Methotrexate
8
Antilymphocyte Serum
8
Cyclosporine
7
peginterferon alfa-2a
6
Hydroxyurea
6
Filgrastim
6
Etoposide
6
Aspirin
6
fludarabine
5
Prednisone
5
Melphalan
5
Imatinib Mesylate
5
Cytarabine
5
Decitabine
4
pomalidomide
3
givinostat hydrochloride
3
givinostat
3
Topotecan
3
Thiotepa
3
Radiotherapy
3
Lenalidomide
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Polycythemia Vera
×
peginterferon alfa-2b
×
Clear all
NCT01387763
2022-04-27
DALIAH
Odense University Hospital
Phase 3
Completed
202 enrolled
NCT01949805
2016-11-28
PROUD-PV
AOP Orphan Pharmaceuticals AG
Phase 3
Completed
257 enrolled